Impact of prior paclitaxel-based chemotherapy on the outcome of salvage high-dose chemotherapy (HDCT) for relapsed germ-cell tumors (GCT): EBMT Solid Tumors Working Party (STWP)-sponsored retrospective study

被引：0

作者：

Necchi, A. ^{[1
]}

Miceli, R. ^{[2
]}

Bregni, M. ^{[3
]}

Berger, L. A. ^{[4
]}

Oechsle, K. ^{[4
]}

Schumacher, K. ^{[5
]}

Apperley, J. ^{[6
]}

Bourhis, J. H. ^{[7
]}

Laszlo, D. ^{[8
]}

Flechon, A. ^{[9
]}

Arpaci, F. ^{[10
]}

Secondino, S. ^{[11
]}

Dreger, P. ^{[12
]}

Crysandt, M. ^{[13
]}

Plueger, K. H. ^{[14
]}

Worel, N. ^{[15
]}

Krueger, W. ^{[16
]}

Ringhoffer, M. ^{[17
]}

Unal, A. ^{[18
]}

Nagler, A. ^{[19
]}

Michieli, M. ^{[20
]}

Campos, A. ^{[21
]}

Wahlin, A. ^{[22
]}

Sucak, G. ^{[23
]}

Schots, R. ^{[24
]}

Donnini, I. ^{[25
]}

Raggi, D. ^{[1
]}

Giannatempo, P. ^{[1
]}

Ifrah, N. ^{[26
]}

Badoglio, M. ^{[27
]}

Martino, M. ^{[28
]}

Pedrazzoli, P. ^{[11
]}

Lanza, F. ^{[29
]}

机构：

[1] Fdn IRCCS Ist Nazl Tumori, Med Oncol, Milan, Italy

[2] Fdn IRCCS Ist Nazl Tumori, Clin Epidemiol & Trials Org Unit, Milan, Italy

[3] Azienda Osped Busto Arsizio, Med Oncol, Busto Arsizio, Italy

[4] KMT Univ Klinikum Hamburg Eppendorf, Med Oncol, Hamburg, Germany

[5] UKGM Marburg Klin Hematol & Oncol, Med Oncol, Marburg, Germany

[6] Univ London Imperial Coll Sci Technol & Med, Hematol, London, England

[7] Gustave Roussy Inst Cancerol, Hematol BMT, Villejuif, France

[8] European Inst Oncol, Hematol BMT, Milan, Italy

[9] Ctr Leon Berard, Hematol, F-69373 Lyon, France

[10] Gulhane Mil Med Acad, GATA BMT Ctr, Ankara, Turkey

[11] Fdn IRCCS Policlin San Matteo, Med Oncol, Pavia, Italy

[12] Univ Klinikum Heidelberg, Hematol, Heidelberg, Germany

[13] Univ Hosp Aachen, Dept Oncol Hematol & SCT, Med Klin 4, Aachen, Germany

[14] EV Diakonie Krankenhaus Gemeinnitzige GmbH, Hematol, Bremen, Germany

[15] Med Univ Vienna, BMT Unit, Vienna, Austria

[16] Univ Med, Klin Innere Med Hamat Onkol C, Greifswal, Germany

[17] Klinikum Karlsruhe gGmbH, Med Klin Haematol 3, Onkol, Karlsruhe, Germany

[18] Kapadokya Cappadocia BMT Ctr, Erciyes Med Sch, Dept Hematol Oncol, Kayseri, Turkey

[19] Chaim Sheba Med Ctr, BMT Unit, IL-52621 Tel Hashomer, Israel

[20] IRCCS Aviano, CRO, Hematol, Aviano, Italy

[21] Inst Portugues Oncol Porto, BMT Unit, Oporto, Portugal

[22] Umea Univ Hosp, Hematol, Umea, Sweden

[23] Gazi Univ Med, Dept Hematol & Stem Cell Transplantat, Ankara, Turkey

[24] Univ Ziekenhuis Brussel, Div Clin Hematol, Brussels, Belgium

[25] Univ Hosp Careggi, BMT Unit, Florence, Italy

[26] CHRU Angers, BMT Unit, Angers, France

[27] EBMT, EBMT Study Off, Paris, France

[28] Azienda Osped BMM, Hematol & Bone Marrow Transplant Unit, Reggio Di Calabria, Italy

[29] Ist Ospitalieri Cremona, Hematol & Bone Marrow Transplant Unit, Cremona, Italy

来源：

BONE MARROW TRANSPLANTATION | 2015年 / 50卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O094

引用

页码：S55 / S55

页数：1

共 50 条

[21] Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party
Necchi, A.
Miceli, R.
Bregni, M.
Bokemeyer, C.
Berger, L. A.
Oechsle, K.
Schumacher, K.
Kanfer, E.
Bourhis, J. H.
Massard, C.
Laszlo, D.
Montoro, J.
Flechon, A.
Arpaci, F.
Secondino, S.
Wuchter, P.
Dreger, P.
Crysandt, M.
Worel, N.
Kruger, W.
Ringhoffer, M.
Unal, A.
Nagler, A.
Campos, A.
Wahlin, A.
Michieli, M.
Sucak, G.
Donnini, I.
Schots, R.
Ifrah, N.
Badoglio, M.
Martino, M.
Raggi, D.
Giannatempo, P.
Rosti, G.
Pedrazzoli, P.
Lanza, F.
BONE MARROW TRANSPLANTATION, 2016, 51 (03) : 384 - 390
[22] Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer
Margolin, KA
Doroshow, JH
Frankel, P
Chow, W
Leong, LA
Lim, D
McNamara, M
Morgan, RJ
Shibata, S
Somlo, G
Twardowski, P
Yen, Y
Kogut, N
Schriber, J
Alvarnas, J
Stalter, S
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (11) : 903 - 911
[23] HIGH-DOSE CHEMOTHERAPY WITH STEM CELL TRANSPLANTATION IN ADULT PRIMARY MEDIASTINAL GERM CELL TUMORS. A RETROSPECTIVE STUDY OF THE EBMT, CELLULAR THERAPY & IMMUNOBIOLOGY WORKING PARTY
Pedrazzoli, Paolo
Badoglio, Manuela
Labopin, Myriam
Rosti, Giovanni
Delaye, Matthieu
Bokemeyer, Carsten
Seidel, Christoph
Apperley, Jane
Metafuni, Elisabetta
Finke, Juergen
Bourhis, Jean-Henri
Kosmas, Christos
Malard, Florent
Kuball, Jurgen
Chabannon, Christian
Ruggeri, Annalisa
Secondino, Simona
BONE MARROW TRANSPLANTATION, 2024, 59 : 620 - 621
[24] Phase II trial of bevacizumab (BEV)/high-dose chemotherapy (HDC) for refractory germ-cell tumors (GCT).
Nieto, Yago
Tannir, Nizar M.
Tu, Shi-Ming
Jones, Roy B.
Zurita, Amado J.
Aparicio, Ana
Bassett, Roland
Margolin, Kim Allyson
Holmberg, Leona
Champlin, Richard E.
Pagliaro, Lance C.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[25] Implementing Indiana regimen salvage high-dose chemotherapy in relapsed germ cell tumors in Slovakia.
Chovanec, Michal
Rusinakova, Zuzana
Ladicka, Miriam
Obertova, Jana
Palacka, Patrik
Rejlekova, Katarina
Sycova-Mila, Zuzana
Orszaghova, Zuzana
Lesko, Peter
Mardiak, Jozef
Vranovsky, Andrej
Mego, Michal
Drgona, Lubos
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
[26] Maintenance oral etoposide (VP-16) after high-dose chemotherapy (HDCT) for patients with relapsed metastatic germ-cell tumors (mGCT).
Anouti, Bilal
Akel, Reem
Althouse, Sandra K.
Abonour, Rafat
Abu Zaid, Mohammad Issam
Hanna, Nasser H.
Einhorn, Lawrence H.
Adra, Nabil
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[27] Risk factors for renal failure (RF) during high-dose chemotherapy (HDCT) and outcomes for patients (pts) with relapsed germ-cell tumors (rGCT).
Zhang, Kevin Juan
Hanna, Nasser H.
Abu Zaid, Mohammad Issam
Abonour, Rafat
Albany, Costantine
Einhorn, Lawrence H.
Adra, Nabil
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[28] High-dose chemotherapy (HDCT) plus peripheral-blood stem-cell transplant (PBSCT) for patients (pts) with relapsed germ-cell tumors (GCT) and active brain metastases (mets).
Kalra, Maitri
Adra, Nabil
Mckay, John
Abonour, Rafat
Hanna, Nasser H.
Einhorn, Lawrence H.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[29] Comparison of three or fewer sequential high-dose chemotherapy cycles as salvage treatment in germ-cell tumors
Goessi, F.
Spahn, M.
Zweifel, M.
Schardt, J.
Thalmann, G.
Pabst, T.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 20 - 20
[30] Retrospective comparison between conventional-dose chemotherapy and high-dose chemotherapy for the treatment of relapsed or metastatic germ cell tumors
Alencar, A. M.
Rinck, J., Jr.
Cezario, L. L.
de Oliveira, T. B.
de Lima, V. C.
Chinen, L. T.
Santos, F. N.
Fanelli, M. F.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)

← 1 2 3 4 5 →